Determination of high-sensitivity cardiac troponin I 99th percentile upper reference limits in a healthy Korean

Misuk Ji1, Hee-Won Moon1, Mina Hur1

  • 1Department of Laboratory Medicine, Konkuk University School of Medicine, Seoul, South Korea.

Clinical Biochemistry
|April 13, 2016
PubMed

Insights

This study established the 99th percentile upper reference limit for cardiac troponin I (cTnI) in a Korean population. Results show lower cTnI levels compared to other ethnicities, influenced by age and selection criteria.

Area of Science:

  • Cardiology
  • Clinical Chemistry
  • Population Health

Background:

  • Establishing accurate reference ranges for cardiac troponin I (cTnI) is crucial for diagnosing myocardial infarction.
  • High-sensitivity assays have improved detection limits, necessitating updated reference values.
  • Population-specific reference limits are important due to potential ethnic and demographic variations.

Purpose of the Study:

  • To determine the 99th percentile upper reference limit (URL) for cardiac troponin I (cTnI) using a high-sensitivity assay in a healthy Korean population.
  • To investigate the influence of age and sex on cTnI levels within this reference population.

Main Methods:

  • Enrolled 854 healthy Korean males and females (mean age 49.8 years).
  • Excluded participants with subclinical conditions based on estimated glomerular filtration rate, glycated hemoglobin, and B-type natriuretic peptide levels.
  • Measured serum cTnI using the ARCHITECT STAT High-Sensitive Troponin-I Assay.

Main Results:

  • The 99th percentile URL for cTnI in the Korean population was 18 ng/L (90% CI, 14-35 ng/L).
  • Specific 99th percentile URLs were 20 ng/L for males and 19 ng/L for females.
  • Median cTnI concentrations were higher in participants aged 50 years and older compared to younger individuals.

Conclusions:

  • The Korean reference population exhibited lower 99th percentile URLs for cTnI compared to other ethnic groups.
  • Factors such as ethnicity, age distribution, and health selection criteria significantly influence cTnI reference limits.
  • These findings underscore the importance of population-specific reference ranges for cTnI assays.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
409
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
733
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.5K